the TGI 1200 system

The TGI 1200 system is a compact, fully automated cell isolation system for the rapid processing of patient-derived fat tissue to separate, isolate and produce large yields of endothelial progenitor cells and stem cells. More Info >

TGI 1200 product specs

Click here to download the full TGI 1200 Spec sheet.

TGI 1200 Video

Download Free Software

To view these files you need current versions of either Windows Media Player or Adobe Acrobat Reader which are freely available at the links below...

Windows Media Player

Click to Download

Adobe Acrobat Reader

Click to Download

Product Candidates

TGI 1200

TGI

TGI 1200 Adipose-Tissue Processing System and Bioheart Acute Cell Therapy

We are seeking to develop Bioheart Acute Cell Therapy, a patient derived cell therapy for the treatment of acute MI. Unlike MyoCell, which is intended to be used to treat severe heart damage months or even years after a heart attack, Bioheart Acute Cell Therapy is being designed to be used for the treatment of muscle damage immediately following a heart attack. We hope to demonstrate that the injection of endothelial progenitor and stem cells derived from fat tissue by the TGI 1200 is a safe and effective means of limiting or reversing some of the effects of acute MI and preventing or slowing a patient's progression from MI to CHF. Fat tissue is an abundant and readily available source of endothelial progenitor and stem cells and is easily extractable from a patient using minimally invasive techniques. If approved, we intend to market the Bioheart Acute Cell Therapy primarily to interventional cardiologists.

We have secured the exclusive, worldwide right to sell or lease to medical practitioners and related healthcare entities the following items for the treatment of acute MI:

•	TGI 1200 and certain disposable products used in conjunction with the TGI 1200, or the TGI Licensed Products;
•	the processes that use the TGI Licensed Products, or the TGI Licensed Processes; and
•	the cells derived using the TGI Licensed Products and/or TGI Licensed Processes.

The TGI 1200 system is a compact, fully automated cell isolation system for the rapid processing of patient-derived fat tissue to separate, isolate and produce large yields of endothelial progenitor cells and stem cells. The fat tissue is extracted from the patient using a minor liposuction-like procedure and processed using the TGI 1200. TGI 1200. The TGI 1200 system produces stem cells from adipose tissue in about 1 hour.

Click here to download the full TGI 1200 Spec sheet.

Candidate	Proposed Use or Indication	Status/Phase
TGI 1200 Adipose Tissue Processing System	Fully automated device for the rapid processing of patient derived fat tissue.	Tissue Genesis performing validation studies and preparing Device Master File.

Comments: Upon approval of IND application for Bioheart Acute Cell Therapy, anticipate seeking cost reimbursement for supplying TGI 1200 and related disposable kits for use in connection with Bioheart Acute Cell Therapy clinical trials, Tissue Genesis expects to file for 510(k) approval in the third quarter of 2008.